NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression [Yahoo! Finance]
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression
NRx Pharmaceuticals, Inc. (NRXP) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]
NRx Pharmaceuticals, Inc. (NRXP) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]
Veru, EyePoint Pharmaceuticals, Sintx Technologies among healthcare movers [Seeking Alpha]